ImmuCell Corp (NASDAQ:ICCC)

7.15
Delayed Data
As of May 23
 0.00 / 0.00%
Today’s Change
5.26
Today|||52-Week Range
9.25
-18.66%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Medical Specialties
MARKET CAP
$42.4M

Company Description

ImmuCell Corp. engages in the development, acquisition, manufacture, and sale of products that improve the health and productivity of cows for the dairy and beef industries. Its products include first defense for scours, California mastitis test kit, and purified nisin intramammary treatment for mastitis. The company was founded in 1982 and is headquartered in Portland, ME.

Contact Information

ImmuCell Corp.
56 Evergreen Drive
Portland Maine 04103
P:(207) 878-2770
Investor Relations:

Employees

Shareholders

Individual stakeholders26.87%
Mutual fund holders10.87%
Other institutional1.87%

Top Executives

Michael F. BrighamPresident, CEO, Secretary, Treasurer & Director
Joseph H. CrabbDirector & Chief Scientific Officer
Bobbi Jo BrockmannDirector & Vice President-Sales & Marketing
Elizabeth L. WilliamsVice President-Manufacturing Operations